SAN DIEGO--(BUSINESS WIRE)--Data was presented at the American Heart Association meeting in Chicago on November 17, 2014 regarding the safety and feasibility of Cytori Cell Therapy using Adipose Derived Regenerative Cells (ADRCs™) administered through the coronary artery in patients with acute ST segment elevated myocardial infarction from the ADVANCE clinical trial sponsored by Cytori Therapeutics, Inc. (NASDAQ: CYTX).
Help employers find you! Check out all the jobs and post your resume.
